The class of chemicals known as NUCB1_MOUSE (nucleobindin 1) inhibitors encompasses a range of compounds that exert their influence primarily through modulation of calcium signaling pathways within cells. These compounds share a common function of altering calcium dynamics, which can affect various calcium-dependent proteins, including NUCB1. The mechanisms of action for these inhibitors are diverse, reflecting the different stages at which calcium signaling can be modulated. For instance, calcium channel blockers such as verapamil, diltiazem, nimodipine, and amlodipine restrict the influx of calcium through voltage-gated calcium channels, which can decrease the activation of calcium-binding proteins like NUCB1. This reduction in intracellular calcium availability can lead to a downstream decrease in the activity of calcium-dependent processes that NUCB1 may influence.
On the other hand, compounds like thapsigargin and cyclopiazonic acid target the endoplasmic reticulum's ability to sequester calcium, leading to a sustained increase in intracellular calcium levels that can disrupt normal cellular functions. SERCA pump inhibitors such as these result in elevated cytosolic calcium, which, while initially might increase NUCB1 activity, over time can lead to calcium dysregulation and potential inactivity of calcium-sensitive proteins due to calcium overload. Chelators like BAPTA-AM work intracellularly to bind free calcium ions, reducing the amount available for proteins like NUCB1 and thus inhibiting their function. Other compounds, such as TMB-8 and 2-APB, influence intracellular calcium release, and Ryanodine modulates the release of calcium from calcium stores, adding another layer of regulation to NUCB1 activity. Caffeine, often known for its other cellular effects, also has the capacity to influence intracellular calcium levels and thus indirectly modulate the activity of NUCB1. Collectively, these NUCB1 inhibitors can alter the calcium-binding ability of NUCB1 by influencing the intracellular calcium concentration, which is central to the function of the protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Another calcium channel blocker that may decrease calcium-dependent processes, potentially affecting NUCB1 function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor which leads to increased cytosolic calcium, could indirectly affect NUCB1 activity due to calcium dysregulation. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
Modulates intracellular calcium release and could indirectly alter NUCB1 activity through its effects on calcium signaling. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Alters the release of calcium from the sarcoplasmic reticulum and could indirectly affect the activity of calcium-binding proteins like NUCB1. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A cell-permeant calcium chelator which can sequester intracellular calcium, potentially influencing NUCB1 activity. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
L-type calcium channel blocker that could indirectly affect calcium-dependent proteins such as NUCB1. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Can mobilize intracellular calcium stores and thus might indirectly modify the activity of NUCB1. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
Inhibitor of the SERCA pump, leading to alteration in calcium homeostasis which could influence NUCB1 activity. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
As a calcium channel blocker, it can lower intracellular calcium levels, potentially affecting NUCB1 function. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
By blocking calcium channels, it may affect calcium-dependent processes and therefore potentially the function of NUCB1. | ||||||